Response to commentaries

dc.contributor.authorMarsden, J.
dc.contributor.authorTai, B.
dc.contributor.authorAli, R.
dc.contributor.authorHu, L.
dc.contributor.authorRush, A.J.
dc.contributor.authorVolkow, N.D.
dc.date.issued2019
dc.descriptionCommentary
dc.description.abstractAbstract unavailable
dc.description.statementofresponsibilityJohn Marsden, Betty Tai, Robert Ali, Lian Hu, Agustus John Rush, Nora D. Volkow
dc.identifier.citationAddiction, 2019; 114(8):1357-1358
dc.identifier.doi10.1111/add.14693
dc.identifier.issn0965-2140
dc.identifier.issn1360-0443
dc.identifier.orcidMarsden, J. [0000-0002-1307-2498]
dc.identifier.orcidAli, R. [0000-0003-2905-8153]
dc.identifier.urihttps://hdl.handle.net/2440/146058
dc.language.isoen
dc.publisherWiley
dc.rights© 2019 Society for the Study of Addiction
dc.source.urihttps://doi.org/10.1111/add.14693
dc.subjectImplementation; interventions; measurement-based care; medications; opioid use disorder; tailored
dc.subject.meshHumans
dc.subject.meshOpioid-Related Disorders
dc.subject.meshAnalgesics, Opioid
dc.titleResponse to commentaries
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections